Prospective Study on Clinical Outcomes of Spontaneous Pneumothorax
Recruiting now
Conditions studied: Pneumothorax, Spontaneous
In brief
Pneumothorax can be fatal if treatment is delayed or the pneumothorax is refractory. However, the mortality rates and their risk factors were mainly reported from retrospective studies, and local data regarding the mortality of spontaneous pneumothorax is scarce. This study aims at evaluating the in-hospital mortality and relevant clinical outcomes of spontaneous pneumothorax and identifying their predictive factors. The data collected from this study will also guide the planning of subsequent research to overcome the knowledge and service gap in managing spontaneous pneumothorax.
Key facts
- Study ID
- NCT05397717
- Run by
- Chinese University of Hong Kong
- People needed
- 349
- Starts
- 2022-10-01
- Expected to finish
- 2026-09-30
- Last updated by the study team
- 2023-02-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients with a confirmed diagnosis of spontaneous pneumothorax on admission or during the hospital stay
- Age greater than 18 years old
- Chinese ethnicity
- Able to sign written informed consent to participate in the study
You may not qualify if…
- Pneumothorax was not found by thoracic imaging
- Traumatic pneumothorax (including iatrogenic pneumothorax)
- Pneumothorax with recent (within one month) lung resection surgery, that may be due to staple line issues
- Trapped lung or non-expandable lungs, without evidence of air leakage
- Patients with psychiatric disease or cognitive impairment that may limit their ability of understanding or giving consent to the study
Where it is running
- Prince of Wales Hospital — Hong Kong, Hong Kong (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.